검색어 : 통합검색[Kim Lyun-Joon.]
-
41
-
The genome sequence of the ethanologenic bacterium Zymomonas mobilis ZM4
-
Seo, Jeong-Sun;
Chong, Hyonyong;
Park, Hyun Seok;
Yoon, Kyoung-Oh;
Jung, Cholhee;
Kim, Jae Joon;
Hong, Jin Han;
Kim, Hyungtae;
Kim, Jeong-Hyun;
Kil, Joon-Il;
Park, Cheol Ju;
Oh, Hyun-Myung;
Lee, Jung-Soon;
Jin, Su-Jung;
Um, Hye-Won;
Lee, Hee-Jong;
Oh, Soo-Jin;
Kim, Jae Young;
Kang, Hyung Lyun;
Lee, Se Yong;
Lee, Kye Joon;
Kang, Hyen Sam;
[1] Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-781, Korea. [2] Department of Biochemistry and Ilchun Molecular Medicine Institute, Medical Research Center, College of Medicine, Seoul National University, Seoul 110-799, Korea. [3] These authors contributed equally to this work.;
[1] Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-781, Korea. [2] Department of Microbiology, School of Biological Sciences, Seoul National University, Seoul 151-742, Korea. [3] These authors contributed equally to this work.;
[1] Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-781, Korea. [2] Department of Computer Science, Ewha Womans University, Seoul, 120-750, Korea.;
Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-781, Korea.;
Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-781, Korea.;
Macrogen Inc., World Meridian Venture Center, 60-24, Gasan-dong, Seoul 153-78;
(Nature biotechnology,
v.23,
2005,
pp.63-68)
-
42
-
Effect of <i>abciximab</i>-coated stent on in-stent intimal hyperplasia in human coronary arteries
-
Hong, Young Joon;
Jeong, Myung Ho;
Kim, Weon;
Lim, Sang Yup;
Lee, Sang Hyun;
Hong, Seo Na;
Kim, Ju Han;
Ahn, Young Keun;
Cho, Jeong Gwan;
Park, Jong Chun;
Cho, Dong Lyun;
Kim, Hoon;
Kang, Jung Chaee;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The Heart Center of Chonnam National University Hospital, Chonnam National University Research Institute of Medical Science, Gwangju, Korea;
The He;
(The American journal of cardiology,
v.94,
2004,
pp.1050-1054)
-
43
-
Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure
-
Park, Joo-Hwan;
Park, Inkeun;
Kim, In-Ho;
Hur, Joon Young;
Hwang, Inhwan;
Kim, Chan;
Kim, Hyo-Jeong;
Maeng, Chi Hoon;
Park, Kwonoh;
Lee, Min-Young;
Lee, Hyo Jin;
Jung, Joo Young;
Keam, Bhumsuk;
Park, Se Hoon;
Lee, Jae Lyun;
;
(Current problems in cancer,
v.46,
2022,
pp.100848)
-
44
-
Comparative Efficacy of Sunitinib versus Sorafenib as First-Line Treatment for Patients with Metastatic Renal Cell Carcinoma
-
Park, Seong Joon;
Lee, Jae-Lyun;
Park, Inkeun;
Park, Kwonoh;
Ahn, Yongcheol;
Ahn, Jin-Hee;
Lee, Dae-Ho;
Ahn, Shin;
Song, Cheryn;
Hong, Jun Hyuk;
Kim, Choung-Soo;
Ahn, Hanjong;
Oncology and;
Oncology and;
Oncology and;
Oncology and;
Oncology and;
Oncology and;
Oncology and;
Cancer Emergency Room, Asan Cancer Centre, University of Ulsan College of Medicine, Seoul, Korea;
Urology, Asan Medical Centre, and;
Urology, Asan Medical Centre, and;
Urology, Asan Medical Centre, and;
Urology, Asan Medical Centre, and;
(Chemotherapy,
v.58,
2013,
pp.468-474)
-
45
-
Prognostic factors for Korean patients with anaplastic thyroid carcinoma
-
Kim, Tae Yong;
Kim, Kyung Won;
Jung, Tae Sik;
Kim, Jung Min;
Kim, Sun Wook;
Chung, Ki-Wook;
Kim, Eun Young;
Gong, Gyungyub;
Oh, Young Lyun;
Cho, Soo Youn;
Yi, Ka Hee;
Kim, Won Bae;
Park, Do Joon;
Chung, Jae Hoon;
Cho, Bo Youn;
Shong, Young Kee;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Seoul National University Hospital, Seoul National University School of Medicine, Seoul, Korea;
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Thyroid Cancer Clinic, National Cancer Center, Koyang, Korea;
Thyroid Cancer Clinic, National Cancer Center, Koyang, Korea;
Thyroid Cancer Clinic, National Cancer Center, Koyang, Korea;
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea;
Department of Pathology, Korea Cancer Center Hospital, Seoul, Korea;
Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Kore;
(Head & neck,
v.29,
2007,
pp.765-772)
-
46
-
The effect of alpha lipoic acid in a porcine in-stent restenosis model
-
Lim, Sang Yup;
Bae, Eun Hui;
Jeong, Myung Ho;
Kim, Ju Han;
Hong, Young Joon;
Sim, Doo Sun;
Kim, Yong Sook;
Park, In Kyu;
Ahn, Youngkeun;
Song, Sun-Jung;
Cho, Dong Lyun;
Kim, Kyoung Seok;
Kang, Jung Chaee;
The Cardiovascular Center of Korea University Ansan Hospital, Seoul, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
The Heart Center of Chonnam National University Hospital, Gwang Ju, Republic of Korea;
Center for Functional Nano Fine Chemicals of Chonnam National University, Gwangju, Republic of Korea;
Center for Functional Nano Fine Chemicals of Chonnam National University, Gwangju, Republic of Korea;
C;
(Journal of cardiology,
v.54,
2009,
pp.375-385)
-
47
-
Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation
-
Kim, Hee-Je;
Yoo, Hea-Lyun;
Lee, Won-Sik;
Kim, Hyeong-Joon;
Kong, Jee Hyun;
Choi, Yunsuk;
Do, Young Rok;
Kwak, Jae-Yong;
Oh, Sukjoong;
Kim, Sung Hyun;
Kim, Jeong-A.;
Zang, Dae Young;
Mun, Yeung-Chul;
Won, Young-Woong;
Lee, Sung-Eun;
Kim, Dong-Wook;
;
(Clinical lymphoma, myeloma & leukemia,
v.17,
2017,
pp.S17-S18)
-
48
-
The Effects of the Heparin-Coated Maximum Arterial Re-Creation (MAC) Stent on Porcine Coronary Stent Restenosis
-
Park, Hyung Wook;
Jeong, Myung Ho;
Jang, Yang Soo;
Kim, Yong Rok;
Kim, Wan;
Park, Woo Suck;
Kim, Nam Ho;
Kim, Joon Woo;
Kim, Sung Hee;
Cho, Jang Hyun;
Ahn, Young Keun;
Cho, Jung Gwan;
Cho, Dong Lyun;
Kim, Hyun Jin;
Park, Jong Chun;
Lee, Jae Hyuck;
Park, Chang Soo;
Kang, Jung Chaee;
;
(순환기 = The Korean circulation journal,
v.29,
1999,
pp.498)
-
49
-
Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea
-
Yoo, Changhoon;
Ryu, Min-Hee;
Huh, Jooryung;
Park, Ji Hyun;
Kang, Hye Jin;
Ahn, Hyo Sook;
Lee, Yongjae;
Kim, Myoung Joon;
Lee, Hyoungnam;
Kim, Tae Won;
Chang, Heung Moon;
Lee, Jae-Lyun;
Kang, Yoon-Koo;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea;
Department of Internal Medicin;
(American journal of hematology,
v.82,
2007,
pp.821-823)
-
50
-
Phase Ib/II umbrella trial to evaluate the safety and efficacy of multiple 2L cancer immunotherapy (CIT) combinations in advanced/metastatic urothelial carcinoma (mUC): MORPHEUS-mUC.
-
Drakaki, Alexandra;
Rezazadeh Kalebasty, Arash;
Lee, Jae-Lyun;
Martin-Liberal, Juan;
Kim, Miso;
Shin, Sang Joon;
Shi, Jane;
Mariathasan, Sanjeev;
Ci, Bo;
Degaonkar, Viraj;
Williams, Patrick;
Cha, Edward;
Maltzman, Julia;
Powles, Thomas;
University of California Los Angeles, Los Angeles, CA;
;
Norton Cancer Institute, Louisville, KY;
;
Asan Medical Center, Seoul, South Korea;
;
ICO l’Hospitalet-Hospital Duran i Reynals, Barcelona, Spain;
;
Seoul National University Hospital, Seoul, South Korea;
;
Yonsei University College of Medicine, Seoul, South Korea;
;
Roche Product Development, Shanghai, China;
;
Genentech, Inc., South San Francisco, CA;
;
Genentech, Inc., South San Francisco, CA;
;
Genentech, Inc., South San Francisco, CA;
;
Genentech, Inc., South San Francisco, CA;
;
Genentech, Inc., South San Francisco, CA;
;
Genentech, Inc., South San Francisco, CA;
;
Barts Cancer Institute, Queen Mary University of London, Royal Free NHS Trust, London, United Kingdom;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.38,
2020,
pp.TPS591-TPS591)